Objective To assess the effect of glucose control on the rate of growth of fetuses in women with pregestational diabetes mellitus (Types 1 and 2). Methods All pregestational diabetic women booked at Mater Mothers’ Hospital, Brisbane, Australia, between 1 January 1994 and 31 December 2002, were included. Pregnancies with congenital fetal anomalies, multiple pregnancies, and pregnancies terminated prior to 20 weeks’ gestation were excluded. Dating scans were performed before 14 weeks’ gestation and serial scans were performed at 18, 24, 28, 32 and 36 weeks. Fetal parameters, including biparietal diameter, femur length and abdominal circumference, were recorded. The daily growth rates for biparietal diameter, femur length, and fetal abdominal ...
Background and objective: The abnormal intrauterine environment in case of maternal diabetes results...
OBJECTIVE — To investigate the maternal demographic and metabolic factors contributing to the growth...
Objectives: Despite improved glycemic control, the rate of large-for-gestational-age (LGA) infants r...
OBJECTIVE — To assess the timing of fetal growth spurt among pre-existing diabetic preg-nancies (typ...
Objective: To detect differences in growth profiles of fetuses of type 1 diabetic mothers, aiming at...
Early embryonic and fetal growth were followed longitudinally in 23 women with type-1 diabetes to in...
OBJECTIVE — To determine maternal parameters with the strongest influence on fetal growth in differe...
Objective: Our aim was to examine the impact of gestational diabetes (GDM), from before the GDM-diag...
Aim: To study about the correlation between the glycemic status and increase in fetal abdominal circ...
Objective: Examine the association between prenatal care and excessive fetal growth outcomes among m...
OBJECTIVE:Our aim was to examine the impact of gestational diabetes (GDM), from before the GDM-diagn...
Aims To evaluate fetal growth in relation to gestational weight gain in women with Type 2 diabetes. ...
OBJECTIVE: To determine whether fetal overgrowth precedes the diagnosis of gestational diabetes mell...
Abstract BACKGROUND: Fetal overgrowth is the most important complication of gestational (GDM) and pr...
Fasting plasma glucose (FPG) concentration measured at the first prenatal visit is a predictor of ge...
Background and objective: The abnormal intrauterine environment in case of maternal diabetes results...
OBJECTIVE — To investigate the maternal demographic and metabolic factors contributing to the growth...
Objectives: Despite improved glycemic control, the rate of large-for-gestational-age (LGA) infants r...
OBJECTIVE — To assess the timing of fetal growth spurt among pre-existing diabetic preg-nancies (typ...
Objective: To detect differences in growth profiles of fetuses of type 1 diabetic mothers, aiming at...
Early embryonic and fetal growth were followed longitudinally in 23 women with type-1 diabetes to in...
OBJECTIVE — To determine maternal parameters with the strongest influence on fetal growth in differe...
Objective: Our aim was to examine the impact of gestational diabetes (GDM), from before the GDM-diag...
Aim: To study about the correlation between the glycemic status and increase in fetal abdominal circ...
Objective: Examine the association between prenatal care and excessive fetal growth outcomes among m...
OBJECTIVE:Our aim was to examine the impact of gestational diabetes (GDM), from before the GDM-diagn...
Aims To evaluate fetal growth in relation to gestational weight gain in women with Type 2 diabetes. ...
OBJECTIVE: To determine whether fetal overgrowth precedes the diagnosis of gestational diabetes mell...
Abstract BACKGROUND: Fetal overgrowth is the most important complication of gestational (GDM) and pr...
Fasting plasma glucose (FPG) concentration measured at the first prenatal visit is a predictor of ge...
Background and objective: The abnormal intrauterine environment in case of maternal diabetes results...
OBJECTIVE — To investigate the maternal demographic and metabolic factors contributing to the growth...
Objectives: Despite improved glycemic control, the rate of large-for-gestational-age (LGA) infants r...